Drug class in one race

Endothelin receptor (ETA/ETB, dual) drugs for Hypertension

2 tracked Endothelin receptor (ETA/ETB, dual) drugs in the Hypertension race. The class explanation lives on the Endothelin receptor (ETA/ETB, dual) page; the full indication pipeline across every mechanism is on the Hypertension page.

2 approved / phase 4

Head-to-head evidence: Aprocitentan vs Bosentan

The roster

← all Endothelin receptor (ETA/ETB, dual) drugs